FINWIRES · TerminalLIVE
FINWIRES

由於伊朗和平協議難以達成,美國股市指數下跌,原油價格和公債殖利率飆升。

By

-- 週三午盤過後,由於市場擔憂伊朗封鎖將延長以迫使德黑蘭達成和平協議,原油期貨和政府公債殖利率大幅上漲,美國股指走低。 權重股Alphabet(GOOG,GOOGL)、亞馬遜(AMZN)、Meta Platforms(META)和微軟(MSFT)將於盤後公佈季度財報,投資者正等待這些超大規模數據中心運營商的最新資本支出計劃,這加劇了市場的緊張情緒。 道瓊工業指數下跌0.6%,收在48,853.3點;標普500指數下跌0.2%,收在7,121.9點;那斯達克指數下跌0.4%,收在24,572.2點。除能源板塊外,所有板塊均下跌,其中材料和工業板塊領跌。 據《華爾街日報》報道,美國官員透露,唐納德·特朗普總統已指示助手做好延長對伊朗封鎖的準備。根據《華爾街日報》報道,在最近的幾次會議上,包括週一在戰情室的討論,川普選擇繼續透過封鎖伊朗港口來打壓伊朗經濟和石油出口。 官員告訴《華爾街日報》,川普與助手們評估後認為,其他選項——恢復轟炸或退出衝突——的風險都比維持對伊朗的封鎖更大。 「伊朗根本就沒辦法好好做人。他們不知道怎麼簽署無核協議。他們最好趕緊醒悟過來!」川普週三在Truth Social上發文說道。 同時,由於擔心川普的政策會延長霍爾木茲海峽的混亂局面,西德州中質原油期貨價格上漲6.7%至每桶106.70美元,布蘭特原油期貨價格飆升6.8%至每桶118.87美元。霍爾木茲海峽是全球20%原油運輸的咽喉要道。 貴金屬方面,受原油價格上漲引發通膨擔憂的影響,黃金期貨下跌0.7%至每盎司4,575美元,白銀期貨下跌2%至每盎司72.30美元。多數美國公債殖利率上漲,其中10年期公債殖利率上漲4.6個基點至4.40%,創近一個月來新高。 2年期公債殖利率上漲7個基點至3.91%。 聯準會聯邦公開市場委員會將於美國東部時間下午2點發布最新政策聲明,隨後聯準會主席鮑威爾將舉行記者會。根據芝加哥商品交易所(CME)的FedWatch工具顯示,該委員會肯定會維持利率不變,維持在3.5%至3.75%的當前目標利率水準。 麥格理銀行的一份報告指出,如果伊朗戰爭持續時間延長,那些尚未採取更明確的緊縮政策傾向的央行(例如美聯儲)和/或通膨率高於目標水準的央行(同樣例如聯準會)可能會顯得反應遲緩。 “我們預計到5月份,央行將採取更為鷹派的立場和行動。” 經濟新聞方面,美國3月新屋開工量較上季成長近11%,達到年化150.2萬套,高於2月的135.6萬套,也高於彭博社總調查中預期的138萬套。 3月建築許可量年減近11%,至137.2萬套,低於預期的139萬套,也低於2月的153.8萬套。

Related Articles

Research

Research Alert: CFRA Downgrades Rating To Sell From Hold On Shares Of Essex Property Trust, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target by $15 to $250 using a narrower equity risk premium and a forward P/FFO of 15.5x, which is in line with the multifamily residential REIT average. We keep our 2026 FFO estimate at $16.15 and lower 2027's by $0.05 to $16.45 on respective revenue projections of $1.94B and $1.98B. Rental revenue is not yet rebounding to historical growth levels. Across the industry, we are seeing inflation in key operating expenses exceeding revenue growth, and this leads to modest gains in cash NOI growth Y/Y. We expect these market conditions to continue as pricing power for ESS and its peers seems to have eased. In particular, ESS has a West Coast portfolio profile that is exposed to significant job layoffs in the technology sector. In our opinion, we have not yet seen the tail risk of major announcements just released in recent weeks. ESS has the challenge of complying with strict housing guidelines in California, leading to the trust historically underperforming peers in other parts of the country.

$ESS
Research

Research Alert: CFRA Keeps Buy Rating On Shares Of Biogen Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target at $236, 13.8x our new 2027 EPS view, a discount to BIIB's five-year historical forward P/E average of 14.1x. We lower our 2026 EPS view to $15.24 from $16.14 to adjust for the impact from acquired IPR&D. We keep our 2027 EPS view at $17.16. BIIB reported a strong start to 2026, with sales of $2.5B and adjusted EPS of $3.57. We see a successful stabilization of the business after years of decline, due to a 12% Y/Y increase in the growth products portfolio. In our view, during the analyst call, management presented a clear strategic vision centered on the pending $5.6B acquisition of Apellis, expected to close in Q2, which can transform BIIB into a growth company by adding two commercial assets, Syfovre and Empaveli. We think the Apellis deal could bridge a revenue gap until 2028, when the company's late-stage pipeline matures. Via this acquisition, BIIB also gains nephrology expertise and an established infrastructure, which could set its key asset Felzartamab launch for success.

$BIIB
Australia

Starbucks to Sustain Sales Momentum; to Focus on Margins in H2, UBS Says

Starbucks (SBUX) is expected to maintain solid sales momentum on its turnaround strategy, though investor focus is shifting toward margin recovery in H2, UBS said in a note on Wednesday.The brokerage said strong transaction-driven comparable sales growth in Q2 reflected improvements in operations, menu innovation and updated loyalty program.Looking ahead, UBS said continued execution on initiatives such as afternoon beverage platforms, loyalty enhancements, store closures and operational improvements should support sales into H2.UBS also expects margin expansion later in the year, supported by sales leverage, cost savings and easing pressures from tariffs and coffee costs.UBS raised the price target on the stock to $105 from $100 but maintained a neutral rating.Price: $106.10, Change: $+8.82, Percent Change: +9.06%

$SBUX